
ASX 200 Gains as Clarity Pharmaceuticals Leads Market
The S&P/ASX 200 rose 10.90 points or 0.14% to 7,865.00 by 3:25 pm AEDT on 18 March 2025. The in…












COLITCO LLP accepts no responsibility for any claim, loss or damage as a result of information provided or its accuracy. The information provided on this site is general in nature, not financial product advice, see a financial expert before making any investment decision. Your personal objectives, financial situation or needs have not been taken into consideration. There may be a conflict of interest present with commercial arrangements with companies and/or stock held. COLITCO LLP or an associate may receive a commission for funds raised.